Advanced Search

 

Study ID Status Title Patient Level Data
111818 Completed OM6X: An Open-Label Extension of a Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Combined Lovaza (previously Omacor®) and Simvastatin Therapy in Hypertriglyceridemic Subjects Study Listed on ClinicalStudyDataRequest.com
111821 Completed A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (formerly known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated with Antara™
111823 Completed A Randomized, Open-Label Study to Evaluate the Safety,Tolerability, Pharmacokinetics, and Pharmacodynamics ofGSK1362885 in Subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
111827 Completed A single-arm, international, multi-center trial investigating the efficacy and safety of ofatumumab retreatment and maintenance in CLL patients who progressed following response or stable disease after ofatumumab treatment in Hx-CD20-406
111829 Completed A single-blinded randomized, placebo-controlled, staggered-parallel, escalating-dose study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of oral SB756050 administered for 6 days to Subjects with Type 2 Diabetes Mellitus Study Listed on ClinicalStudyDataRequest.com
111834 Completed A randomised, double-blind, placebo-controlled, 2-period cross-over study to evaluate the effect of treatment with GSK2190915 on the allergen-induced asthmatic response in subjects with mild asthma Study Listed on ClinicalStudyDataRequest.com
111848 Completed An open-label, non-randomized [11C]carfentanil PET study in healthy male subjects to investigate brain mu-opioid receptor occupancy, pharmacokinetics, and pharmacodynamics of single oral doses of GSK1521498 and naltrexone. Study Listed on ClinicalStudyDataRequest.com
111849 Completed A randomised, double-blind, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamic effects of 10 days of repeat dosing of GSK1521498 in overweight or obese but otherwise healthy subjects. Study Listed on ClinicalStudyDataRequest.com
111850 Completed A 35-Day, Multi-Centre, Randomised, Parallel-Group, Double-Blind, Placebo-Controlled Proof of Concept Study to Investigate the Effects of GSK1521498 on Body Weight and Composition, Eating Behaviour and Related Brain Function, in Obese Subjects with Over-Eating Behaviours. Study Listed on ClinicalStudyDataRequest.com
111852 Completed Immunogenicity and safety study of Kinrix® co-administered with Varivax® Study Listed on ClinicalStudyDataRequest.com
111861 Completed A Pharmacokinetic Interaction Study Evaluating the Effect of Reliant Pharmaceuticals Inc. (Lovaza®) Omega-3-Acid Ethyl Esters Capsules on the Plasma Pharmacokinetics of Reliant Pharmaceuticals Inc. (Antara™) Fenofibrate Capsules in Healthy Adult Volunteers Under Fasting Conditions
111863 Completed A Pharmacokinetic Interaction Study Evaluating the Effect of Reliant Pharmaceuticals Inc. (Lovaza®) Omega-3-Acid Ethyl Esters Capsules on the Plasma Pharmacokinetics of Parke Davis (Lipitor®) Atorvastatin Tablets in Healthy Adult Volunteers Under Fasting Conditions Study Listed on ClinicalStudyDataRequest.com
111864 Completed A Pharmacokinetic Interaction Study Evaluating the Effect of Omega-3-Acid Ethyl Esters Capsules (Omacor®; Reliant Pharmaceuticals Inc.) on the Plasma Pharmacokinetics of Rosuvastatin Tablets (Crestor®; AstraZeneca) in Healthy Adult Volunteers under Fasting Conditions. Study Listed on ClinicalStudyDataRequest.com
111867 Completed A pilot single-dose, 6-treatment, 4-period crossover relative bioavailability study of a fixed-dose combination of omega3+fenofibrate vs. Omacor+AntaraTM vs Antara alone n healthy adults under fed and fasted conditions
111870 Completed A phase II, randomized, observer blind, controlled, multicenter study to assess immunogenicity and antibody persistence following vaccination with GSK's candidate combined measles, mumps, and rubella vaccine (MMR) versus M-M-R® II as a first dose, both administered subcutaneously at 12-15 months of age, concomitantly with hepatitis A vaccine (HAV), varicella vaccine (VV) and pneumococcal conjugate vaccine (PCV) but at separate sites. Study Listed on ClinicalStudyDataRequest.com
111891 Completed An Evaluation of Lung Function and Symptoms in Patients with Chronic Obstructive Pulmonary Disease (COPD) on Long-Acting Bronchodilator Monotherapy
111914 Completed A Single-Blind, Randomised, Placebo-Controlled Study to Evaluate Safety, Tolerability and Pharmacokinetics of Single Oral Escalating Doses of GSK1360707 Study Listed on ClinicalStudyDataRequest.com
111924 Completed A randomized, double-blind, placebo controlled, incomplete block, 3 way cross over study in subjects with allergic rhinitis to assess the effect of intranasal repeat doses of SB-705498 when administered alone or in conjunction with intranasal fluticasone propionate on the symptoms of rhinitis in the Vienna allergen challenge chamber Study Listed on ClinicalStudyDataRequest.com
111925 Completed A randomized, double blind, placebo controlled study to assessthe effect of intranasal single dose SB-705498 on the response tointranasal capsaicin challenge in non-allergic rhinitis patients Study Listed on ClinicalStudyDataRequest.com
111951 Completed First trimester Paroxetine use and the occurrence of congenital malformations: Systematic review and meta-analysis of epidemiological data
111954 Completed Non-inferiority study of GSK Biologicals’ Pandemic influenza vaccine 1562902A. Study Listed on ClinicalStudyDataRequest.com
111955 Completed Safety study of GSK Biologicals’ human papillomavirus vaccine (GSK580299) in female American and Canadian subjects who had received control vaccine in study 580299/008
111960 Terminated AVANDIA CV Outcomes Study: Thiazolidinedione Intervention with vitamin D Evaluation (TIDE) A Multicenter Randomized Double-Blind Placebo-Controlled Trial of a Thiazolidinedione or Placebo and of Vitamin D or Placebo In People With Type 2 Diabetes at Risk For Cardiovascular Disease Study Listed on ClinicalStudyDataRequest.com
111982 Completed Post-marketing carcinogenicity study of Bupropion
111983 Completed Fluticasone propionate nasal spray (Flixonase) safety in patients with allergic rhinitis registered in the UK General Practice Research Database

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.